NCT01348763View on ClinicalTrials.gov

The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

May 31, 2012

Conditions
HIV
Interventions
DRUG

Maraviroc

Maraviroc 150 mg daily

DRUG

Truvada

daily until 10. day then stop

DRUG

Darunavir

daily until 10. day then stop

Trial Locations (1)

W2 1NY

Imperial College Healthcare NHS Trust, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT01348763 - The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study | Biotech Hunter | Biotech Hunter